Jeffrey B. Madden

About

Jeffrey B. Madden is a biotech executive and former institutional investment manager. He is the co-founder and Chief Executive Officer of ADvantage Therapeutics and has also been identified publicly as Chairman/Executive Chair of Klothea Bio, a longevity-focused subsidiary. Earlier in his career, he served as a portfolio manager at RMB Capital and, per ADvantage's official biography, was also a partner and portfolio manager at IronBridge Capital Management.

Areas of interest